An 80-year-old woman was admitted to our hospital with a complaint of progressive dyspnea for the last month. She had a history of rhemautical mitral stenosis, type 2 diabetes mellitus,…
Abstract Currently percutaneous aortic valve replacement (PAVR) is indicated for patients at high surgical risk or for inoperable patients. Preprocedural evaluation is crucial to select the patients who will benefit…
Abstract Cardiac allograft vasculopathy (CAV) is the most common cause of long-term graft failure after heart transplantation. In the absence of a specific treatment for this condition, percutaneous coronary revascularization…
Contrast-induced nephropathy (CIN) is a serious complication following percutaneous coronary interventions (PCI) . The amount of injected contrast media is a well established risk factor for CIN . We assessed…
Abstract Currently available techniques for the endovascular treatment of infrainguinal arterial chronic total occlusions (CTOs) require long procedure duration, large contrast volumes, complex subintimal dissection technique, and have low-intermediate success…
Abstract Background Carotid artery stenting (CAS) is a reasonable alternative to carotid endarterectomy, especially in patients at high risk for surgery. Carotid stent thrombosis can cause thrombembolic events, but fortunately,…
Abstract Valve stents are small cylindrical structures introduced in stenosed valves to replace them and restore blood flow. High radial force has become an essential feature of these stents. The…
Abstract Endovascular treatment (stenting) has evolved as an effective and safe treatment modality for symptomatic subclavian and innominate artery disease. Most of these patients have comorbid conditions associated with atherosclerotic…
Abstract Background A reduction in right ventricular function commonly occurs in the early postoperative period after coronary artery bypass graft surgery (CABG). We sought to determine the longer-term effect of…
Abstract Objectives This study aimed to report the in-hospital and 30-day event rates in patients undergoing non-emergent, high-risk percutaneous coronary intervention (PCI) and to evaluate whether the Impella Recover LP…
